Metacognitive therapy self-help for anxiety-depression: Single-blind randomized feasibility trial in cardiovascular disease.
Adrian WellsDavid ReevesCalvin HealPeter L FisherPatrick DohertyLinda M DaviesAnthony HeagertyLora CapobiancoPublished in: Health psychology : official journal of the Division of Health Psychology, American Psychological Association (2022)
Home-MCT was acceptable and feasible to deliver to CR patients experiencing anxiety and depression, and the feasibility of conducting a full-scale trial of the intervention was established. Home-MCT may provide additional treatment options for cardiac patients experiencing psychological distress. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
Keyphrases
- end stage renal disease
- cardiovascular disease
- chronic kidney disease
- ejection fraction
- phase iii
- healthcare
- randomized controlled trial
- peritoneal dialysis
- clinical trial
- prognostic factors
- phase ii
- type diabetes
- study protocol
- stem cells
- depressive symptoms
- emergency department
- sleep quality
- left ventricular
- coronary artery disease
- cardiovascular risk factors
- smoking cessation